Page last updated: 2024-08-21

megestrol acetate and Endometrial Neoplasms

megestrol acetate has been researched along with Endometrial Neoplasms in 90 studies

Research

Studies (90)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's12 (13.33)18.2507
2000's29 (32.22)29.6817
2010's33 (36.67)24.3611
2020's16 (17.78)2.80

Authors

AuthorsStudies
Fu, HC; Kung, FT; Lan, J; Lan, KC; Lin, H; Ou, YC; Tsai, YC; Wu, CH1
Ascione, M; Bifulco, G; Boccia, D; Buonfantino, C; Cafasso, V; De Angelis, MC; Della Corte, L; Giampaolino, P; Grasso, G; Gullo, G; Mercorio, A; Palumbo, M; Serafino, P; Verrazzo, P; Viciglione, F1
Liu, Z; Niu, J; Shi, C; Zhao, X1
Chen, X; Guan, J; Liao, J; Shan, W; Shao, W; Xu, Z; Yang, B1
Forget, AN; Kulkarni, A; Mallick, R; Ramsay, T; Weberpals, JI; Wright, NMA1
Chen, XJ; Cheng, YL; Du, Y; Guan, J; Gulinazi, Y; Liu, J; Luo, XZ; Ma, FH; Ning, CC; Shan, WW; Sun, L; Yang, BY; Yu, M; Zhang, HW; Zhu, Q1
Atiomo, W1
da Silva, VF; de Melo, AC; Paulino, E1
Gowri, V; Rawahi, TA; Shikeli, S1
Aghajani, R; Arab, M; Ghahghaei-Nezamabadi, A; Khalagi, K; Sadeghi, S; Tehranian, A1
Christianson, MS; Cordeiro Mitchell, CN; Garbose, RA; Gornet, ME; Hunkler, KF; Maher, JY; Whiting-Collins, LJ1
Chung, YS; Kim, S; Kim, SW; Kim, YT; Lee, JY; Nam, EJ; Park, E; Woo, HY1
He, Y; Wang, J; Wang, Y; Zhou, R1
Cho, A; Kim, DY; Kim, JH; Kim, YM; Kim, YT; Lee, SW; Park, JY; Suh, DS1
Catena, U; Fanfani, F; Masciullo, V; Moroni, R; Scambia, G; Trivellizzi, N; Zannoni, G1
Chen, X; Cheng, Y; Luo, X; Lv, Q; Shan, W; Sun, L; Wu, P; Yang, B; Zhang, H; Zhu, Q1
Choi, YM; Kim, H; Kim, SH; Kim, SW; Ku, SY; Suh, CS1
Li, L; Lin, J; Lou, H; Wang, F; Xu, H; Yu, A; Yu, H; Zhang, X1
Dellinger, TH; Finlay, J; Glackin, CA; Han, ES; Lowe, G; Roberts, CM; Wen, W1
Chen, X; Luo, X; Ning, C; Shan, W; Shi, Y; Xie, B; Xie, L; Xu, Y; Yang, B; Zhang, H; Zhu, Q1
Liu, H; Wang, H; Wang, J; Wang, Y; Zhou, R1
Basaran, D; Boran, N; Comert, GK; Kar, I; Karalok, A; Kilic, C; Turan, T; Turkmen, O; Yucel, O1
Jiang, ZX; Ju, XZ; Ren, YL; Shan, BE; Sun, JM; Tu, XY; Wang, HY; Zang, RY1
Bae, DS; Kim, DY; Kim, JH; Kim, JW; Kim, TJ; Kim, YM; Kim, YT; Nam, JH; Park, JY1
Dongol, S; Gao, X; Jiang, J; Lv, QT; Qiu, C1
Cao, DY; Cheng, NH; Deng, CY; He, FF; Huang, HF; Shen, K; Sun, ZY; Yang, JX; Yu, M; Yu, Q1
Burke, JJ; Davidson, SA; Downey, G; Filiaci, VL; Fleming, GF; Hanjani, P; Leslie, KK; Makker, V; Marzullo, B; Pearl, M; Reyes, HD; Van Le, L; Walker, JL; Zaino, RJ; Zweizig, SL1
Clarke, BA; Feigenberg, T; Ferguson, SE; Gien, LT; Ismiil, N; Laframboise, S; Massey, C; Simpson, AN1
Bogani, G; Carnelli, M; Frigerio, L; Grosso, G; Rossetti, D; Vitale, SG1
Bulun, SE; Coon, JS; Dyson, M; Kim, JJ; Malpani, S; Mittal, N; Ono, M; Pavone, ME; Schink, JC1
Bidadi, S; Foroughi, M; Ghojazadeh, M; Melli, MS; Tabrizi, AD1
Del Giudice, M; Falcone, F; Greggi, S; Laurelli, G; Losito, S; Messalli, EM; Scaffa, C1
Bi, Y; Chen, M; Jin, Y; Li, Y; Pan, L; Shan, Y1
Behbakht, K; Birrer, MJ; Burke, JJ; Downey, G; Filiaci, VL; Fleming, GF; Hanjani, P; Leslie, KK; Makker, V; Myers, AP; Pearl, M; Van Hummelen, P; Zhang, Y; Zweizig, S1
Cetinkaya, N; Erkaya, S; Gungor, T; Yalcin, H; Zergeroglu, S1
Di Napoli, M; Falcone, F; Granata, V; Greggi, S; Laurelli, G; Losito, S1
Chetaille, E; Geniaux, A; Green, JA; Hall, G; Joly, F; Kutarska, E; Lisyanskaya, A; Melichar, B; Oaknin, A; Ostapenko, V; Pautier, P; Reed, N; Shoaib, M; Vergote, I; Zvirbule, Z1
Franco, EL; Gotlieb, WH; Greenwald, ZR; Huang, LN; Wissing, MD1
Baiocco, E; Carosi, M; Corrado, G; Vizza, E1
Ergun, B; Iyibozkurt, C; Kalelioğlu, I; Topuz, S1
Han, AR; Kim, DY; Kim, JH; Kim, YM; Kim, YT; Kwon, YS; Nam, JH1
Buist, MR; Dahhan, T; Fons, G; Ten Kate, FJ; van der Velden, J1
Eftekhar, Z; Izadi-Mood, N; Mohagheghi, S; Rezaei, Z; Shojaei, H; Yarandi, F1
Bogliatto, F; Leidi, L; Morero, S; Mosso, L; Sodano, M; Torchio, B1
Huo, Z; Lang, JH; Shen, K; Wu, M; Yang, JX; Yu, M1
Hahn, HS; Hong, JS; Hong, SR; Kim, TJ; Kwon, YS; Lee, IH; Lee, KH; Lim, JY; Lim, KT; Mok, JE; Park, SJ; Shim, JU; Yoon, SG1
Chen, Y; Lv, W; Mao, Y; Wan, X; Xie, X1
Lee, S; Lim, MC; Seo, SS1
Del Giudice, M; Di Vagno, G; Greggi, S; Laurelli, G; Losito, S; Scaffa, C1
Park, H; Seong, SJ; Yoon, BS1
Eftekhar, Z; Khazaeipour, Z; Shirali, E; Shojaei, H; Yarandi, F1
Feng, CP; Jin, Y; Li, HJ; Lin, H; Pan, XY; Wang, YN1
Atkins, KA; Hanley, KZ; Mentrikoski, MJ; Shah, AA1
Bae, DS; Kim, DY; Kim, JH; Kim, JW; Kim, KR; Kim, SM; Kim, TJ; Kim, YM; Kim, YT; Nam, JH; Park, JY; Seong, SJ1
Cui-Ping, F; Hua, L; Hua-Jun, L; Xiao-Yu, P; Ya-Nan, W; Yan, J1
Bae, DS; Kim, JW; Kim, SM; Kim, TJ; Nam, JH; Park, JY; Seong, SJ1
Bae, DS; Kim, DY; Kim, JH; Kim, JW; Kim, TJ; Kim, YM; Kim, YT; Lee, SH; Nam, JH; Park, JY; Seong, SJ1
Deavers, MT; Gershenson, DM; Malpica, A; Parlow, AF; Silva, EG1
Aksu, T; Ayhan, A; Bozdag, G; Yarali, H1
Herzog, TJ1
Andersen, W; Brunetto, VL; Fiorica, JV; Hanjani, P; Lentz, SS; Mannel, R1
Balos, LL; Dare, AO; Fenstermaker, RA; Gruber, T; Lele, S1
Blanchard, R; Hamid, AM; Leiser, AL1
Aoki, D; Banno, K; Nozawa, S; Susumu, N; Suzuki, A; Suzuki, N; Tamada, Y1
Chang, YC; Huang, SY; Jung, SM; Lai, CH; Ng, KK1
Chang, CL; Chen, CP; Wang, KL; Wu, CC; Yang, YC1
Frumovitz, M; Gershenson, DM1
Kadioğlu, P; Ozguroglu, M; Turna, H; Yildiz, O1
Mlyncek, M; Ravinger, J; Uharcek, P1
Lin, QH; Zhang, Y1
Aydiner, A; Karagol, H; Kucucuk, S; Saip, P; Topuz, E; Uygun, K1
Denschlag, D; Gilbert, L; Kerim-Dikeni, A; Patel, S; Souhami, L; Tan, L1
Del Priore, G; Hartzfeld, KM; Hurst, SA1
Ayhan, A; Bozdag, G; Demirol, A; Gurgan, T1
Baker, TR; Cornelison, TL; Driscoll, DL; Piver, MS1
Chao, AS; Hsueh, S; Lai, CH; Soong, YK1
Bigler, LR; Gams, RA; Spencer, DM; Wilkin, JK1
Borruto Caracciolo, G; Caccavale, C; Cardone, A; Di Serio, C; Tolino, A1
Rose, PG1
Brady, MF; Lentz, SS; Major, FJ; Reid, GC; Soper, JT1
Cavanagh, D; Fiorica, JV; Hoffman, MS; Nicosia, SV; Pinelli, DM; Roberts, WS1
Ghosh, K; Holschneider, CH; Kim, YB; Montz, FJ; Nieberg, RK1
Hyder, SM; Murthy, L; Stancel, GM1
Scribner, DR; Walker, JL1
Jacques, SM; Kowalczyk, CL; Leach, RE; Malone, J; Peterson, EP1
Eltabbakh, GH; Garafano, LL; Hammond, JM; Moody, J1
Hoffmann, O; Oberhoff, C; Schindler, AE; Winkler, UH1
Bender, D; Davis, W; Lowe, MP; Sood, AK; Sorosky, JI; Syrop, CH1
Emons, G; Hinney, B; Huschmand, H; Krauss, T; Viereck, V1
Chou, HH; Hsueh, S; Huang, HJ; Lai, CH; Soong, YK; Wang, CB; Wang, CJ1

Reviews

8 review(s) available for megestrol acetate and Endometrial Neoplasms

ArticleYear
Fertility-Sparing Approach in Patients with Endometrioid Endometrial Cancer Grade 2 Stage IA (FIGO): A Qualitative Systematic Review.
    BioMed research international, 2022, Volume: 2022

    Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Ki-67 Antigen; Levonorgestrel; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; NF-E2-Related Factor 2; Pregnancy; Progestins; Survivin

2022
Conservative management of grade 2 stage IA endometrial carcinoma and literature review.
    The journal of obstetrics and gynaecology research, 2021, Volume: 47, Issue:3

    Topics: Antineoplastic Agents, Hormonal; Conservative Treatment; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Megestrol Acetate; Pregnancy; Retrospective Studies; Treatment Outcome

2021
Fertility-sparing management of low-grade endometrial stromal sarcoma: analysis of an institutional series and review of the literature.
    European journal of obstetrics, gynecology, and reproductive biology, 2015, Volume: 195

    Topics: Adolescent; Adult; Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Cohort Studies; Disease Management; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Hysteroscopy; Megestrol Acetate; Neoplasm Grading; Neoplasm Staging; Organ Sparing Treatments; Pilot Projects; Pregnancy; Pregnancy Rate; Sarcoma; Uterus; Young Adult

2015
[Conservative hormonal therapy for endometrial cancer].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 10

    Topics: 17 alpha-Hydroxyprogesterone Caproate; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Female; Humans; Hydroxyprogesterones; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; Neoplasm Staging; Treatment Outcome

2004
Fertility-sparing therapy for young women with endometrial cancer.
    Expert review of anticancer therapy, 2006, Volume: 6, Issue:1

    Topics: Adult; Age of Onset; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Female; Humans; Infertility, Female; Medroxyprogesterone Acetate; Megestrol Acetate; Patient Selection; Pregnancy; Pregnancy Outcome; Prognosis

2006
Preserving fertility before assisted reproduction in women with endometrial carcinoma: case report and literature review.
    Reproductive biomedicine online, 2007, Volume: 15, Issue:5

    Topics: Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fertility; Humans; Megestrol Acetate; Minimally Invasive Surgical Procedures; Reproductive Techniques, Assisted

2007
Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Report of seven cases and review of the literature.
    Cancer, 1997, Jan-15, Volume: 79, Issue:2

    Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Female; Humans; Megestrol Acetate; Premenopause; Treatment Outcome

1997
[Hormonal therapy and chemotherapy of endometrial cancer].
    Zentralblatt fur Gynakologie, 2002, Volume: 124, Issue:1

    Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Endometrial Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Staging; Palliative Care

2002

Trials

15 trial(s) available for megestrol acetate and Endometrial Neoplasms

ArticleYear
Levonorgestrel-releasing intrauterine device plus metformin, or megestrol acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial carcinoma: a prospective, randomized, blind-endpoint design trial pr
    Reproductive health, 2022, Nov-04, Volume: 19, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Megestrol Acetate; Metformin; Obesity; Pregnancy; Prospective Studies; Randomized Controlled Trials as Topic

2022
Comparison of the effect of oral megestrol acetate with or without levonorgestrel-intrauterine system on fertility-preserving treatment in patients with early-stage endometrial cancer: a prospective, open-label, randomized controlled phase II trial (Clini
    Journal of gynecologic oncology, 2023, Volume: 34, Issue:1

    Topics: Endometrial Neoplasms; Endometrium; Female; Humans; Levonorgestrel; Megestrol Acetate; Prospective Studies

2023
Metformin plus megestrol acetate compared with megestrol acetate alone as fertility-sparing treatment in patients with atypical endometrial hyperplasia and well-differentiated endometrial cancer: a randomised controlled trial.
    BJOG : an international journal of obstetrics and gynaecology, 2020, Volume: 127, Issue:7

    Topics: Adolescent; Adult; Antineoplastic Agents, Hormonal; China; Drug Therapy, Combination; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Megestrol Acetate; Metformin; Middle Aged; Treatment Outcome; Young Adult

2020
The impact of adjunctive metformin to progesterone for the treatment of non-atypical endometrial hyperplasia in a randomized fashion, a placebo-controlled, double blind clinical trial.
    Journal of gynecology obstetrics and human reproduction, 2021, Volume: 50, Issue:6

    Topics: Adult; Antineoplastic Agents, Hormonal; Double-Blind Method; Drug Therapy, Combination; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Megestrol Acetate; Metformin

2021
Temsirolimus with or without megestrol acetate and tamoxifen for endometrial cancer: a gynecologic oncology group study.
    Gynecologic oncology, 2014, Volume: 132, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Drug Administration Schedule; Endometrial Neoplasms; Female; Humans; Immunohistochemistry; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Sirolimus; Tamoxifen

2014
Antiproliferative effect of metformin on the endometrium--a clinical trial.
    Asian Pacific journal of cancer prevention : APJCP, 2014, Volume: 15, Issue:23

    Topics: Adult; Antineoplastic Agents, Hormonal; Atrophy; Carcinoma, Endometrioid; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Humans; Hypoglycemic Agents; Megestrol Acetate; Metformin; Metrorrhagia

2014
Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study.
    Gynecologic oncology, 2016, Volume: 141, Issue:1

    Topics: Class I Phosphatidylinositol 3-Kinases; Endometrial Neoplasms; Female; Humans; Megestrol Acetate; Mutation; Phosphatidylinositol 3-Kinases; Prospective Studies; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Sirolimus; Tamoxifen; Tuberous Sclerosis Complex 1 Protein; Tumor Suppressor Proteins

2016
A Phase 2, Randomized, Open-Label Study of Irosustat Versus Megestrol Acetate in Advanced Endometrial Cancer.
    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2017, Volume: 27, Issue:2

    Topics: Aged; Antineoplastic Agents, Hormonal; Disease-Free Survival; Endometrial Neoplasms; Female; Humans; Megestrol Acetate; Neoplasm Recurrence, Local; Receptors, Estrogen; Sulfonic Acids

2017
Conservative treatment of early endometrial cancer: preliminary results of a pilot study.
    Gynecologic oncology, 2011, Volume: 120, Issue:1

    Topics: Adult; Antineoplastic Agents, Hormonal; Combined Modality Therapy; Endometrial Neoplasms; Female; Fertility; Humans; Hysteroscopy; Intrauterine Devices, Medicated; Levonorgestrel; Megestrol Acetate; Neoplasm Staging; Pilot Projects; Prospective Studies

2011
Phase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study.
    Gynecologic oncology, 2004, Volume: 92, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Endometrioid; Cell Differentiation; Down-Regulation; Drug Administration Schedule; Endometrial Neoplasms; Female; Humans; Megestrol Acetate; Middle Aged; Receptors, Progesterone; Tamoxifen

2004
Reevaluating the safety of fertility-sparing hormonal therapy for early endometrial cancer.
    Gynecologic oncology, 2005, Volume: 99, Issue:2

    Topics: Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Chromosomes, Human, X; Endometrial Neoplasms; Estrogen Receptor alpha; Female; Fertility; Humans; Immunohistochemistry; Megestrol Acetate; Neoplasm Recurrence, Local; Ovarian Neoplasms; Prospective Studies; Receptors, Androgen; Receptors, Progesterone; Treatment Failure; X Chromosome Inactivation

2005
Cisplatin, adriamycin, etoposide, megestrol acetate versus melphalan, 5-fluorouracil, medroxyprogesterone acetate in the treatment of endometrial carcinoma.
    Gynecologic oncology, 1995, Volume: 59, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Endometrial Neoplasms; Etoposide; Female; Fluorouracil; Humans; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Melphalan; Middle Aged; Prospective Studies; Survival Rate

1995
Tamoxifen, megestrol acetate, and beta interferon in endometrial cancer.
    European journal of gynaecological oncology, 1995, Volume: 16, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Endometrial Neoplasms; Female; Humans; Interferon-beta; Megestrol; Megestrol Acetate; Middle Aged; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen

1995
High-dose megestrol acetate in advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:2

    Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Disease-Free Survival; Endometrial Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local; Treatment Outcome

1996
Chemotherapy plus sequential hormonal therapy for advanced and recurrent endometrial carcinoma: a phase II study.
    Gynecologic oncology, 1996, Volume: 60, Issue:3

    Topics: Adult; Aged; Carboplatin; Carcinoma; Disease Progression; Drug Therapy, Combination; Endometrial Neoplasms; Female; Humans; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local; Receptors, Estrogen; Receptors, Progesterone; Survival Analysis; Tamoxifen

1996

Other Studies

67 other study(ies) available for megestrol acetate and Endometrial Neoplasms

ArticleYear
The role of prolonged progestin treatment and factors predicting successful fertility-sparing treatment for early endometrial endometrioid adenocarcinoma.
    European journal of obstetrics, gynecology, and reproductive biology, 2021, Volume: 267

    Topics: Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Megestrol Acetate; Pregnancy; Progestins; Retrospective Studies; Treatment Outcome

2021
Should we abandon hormonal therapy in endometrial cancer? Outcomes of recurrent and metastatic endometrial cancer treated with systemic progestins.
    Cancer medicine, 2023, Volume: 12, Issue:15

    Topics: Antineoplastic Combined Chemotherapy Protocols; Endometrial Neoplasms; Female; Humans; Megestrol Acetate; Neoplasm Recurrence, Local; Progestins; Retrospective Studies

2023
Is there any move to use metformin for endometrial hyperplasia in routine clinical practice?
    BJOG : an international journal of obstetrics and gynaecology, 2020, Volume: 127, Issue:7

    Topics: Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Humans; Hypoglycemic Agents; Megestrol Acetate; Metformin

2020
Endometrioid Carcinoma Arising from an Endometriosis-Associated Abdominal Wall Scar.
    The American journal of case reports, 2020, Jun-01, Volume: 21

    Topics: Abdominal Wall; Carcinoma, Endometrioid; Cicatrix; Endometrial Neoplasms; Endometriosis; Female; Humans; Hysterectomy; Megestrol Acetate; Middle Aged; Salpingo-oophorectomy

2020
Fertility-Sparing Treatment in Young Women with Atypical Endometrial Hyperplasia and Low-Grade Endometrial Cancer: A Tertiary Center Experience.
    JBRA assisted reproduction, 2020, 10-06, Volume: 24, Issue:4

    Topics: Adult; Antineoplastic Agents, Hormonal; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Megestrol Acetate; Treatment Outcome; Young Adult

2020
Conservatively treated endometrial intraepithelial neoplasia/cancer: Risk of intrauterine synechiae.
    Journal of gynecology obstetrics and human reproduction, 2021, Volume: 50, Issue:5

    Topics: Adult; Carcinoma in Situ; Conservative Treatment; Contraceptive Agents, Female; Dilatation and Curettage; Endometrial Neoplasms; Female; Gynatresia; Humans; Hysteroscopy; Intrauterine Devices, Medicated; Levonorgestrel; Live Birth; Megestrol Acetate; Pregnancy; Pregnancy Outcome; Progestins; Retrospective Studies; Risk

2021
Mismatch repair status influences response to fertility-sparing treatment of endometrial cancer.
    American journal of obstetrics and gynecology, 2021, Volume: 224, Issue:4

    Topics: Adult; Antineoplastic Agents, Hormonal; Biomarkers; Biopsy; Disease Progression; DNA Mismatch Repair; DNA Polymerase II; Endometrial Neoplasms; Endometrium; Female; Fertility Preservation; Humans; Hysterectomy; Intrauterine Devices, Medicated; Medroxyprogesterone Acetate; Megestrol Acetate; Middle Aged; Mutation; Neoplasm Recurrence, Local; Prognosis; Receptors, Progesterone; Retrospective Studies; Tumor Suppressor Protein p53; Young Adult

2021
Oncologic and obstetrical outcomes after fertility-preserving retreatment in patients with recurrent atypical endometrial hyperplasia and endometrial cancer.
    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2020, Volume: 30, Issue:12

    Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Gonadotropin-Releasing Hormone; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Outcome; Retreatment; Retrospective Studies; Young Adult

2020
Continued medical treatment for persistent early endometrial cancer in young women.
    Gynecologic oncology, 2021, Volume: 160, Issue:2

    Topics: Administration, Oral; Antineoplastic Agents, Hormonal; Biopsy; Carcinoma, Endometrioid; Disease-Free Survival; Drug Administration Schedule; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Fertility Preservation; Follow-Up Studies; Humans; Intrauterine Devices; Levonorgestrel; Magnetic Resonance Imaging; Medroxyprogesterone Acetate; Megestrol Acetate; Myometrium; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Prognosis; Retrospective Studies; Time Factors; Treatment Failure; Treatment Outcome; Ultrasonography

2021
Prognostic impact of hysteroscopic resection of endometrial atypical hyperplasia-endometrioid intraepithelial neoplasia and early-stage cancer in combination with megestrol acetate.
    American journal of obstetrics and gynecology, 2021, Volume: 224, Issue:4

    Topics: Abortion, Spontaneous; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Combined Modality Therapy; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Fertilization in Vitro; Humans; Hysteroscopy; Live Birth; Megestrol Acetate; Pregnancy; Pregnancy Rate; Prognosis; Prospective Studies

2021
A successful live birth with in vitro fertilization and thawed embryo transfer after conservative treatment of recurrent endometrial cancer.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2018, Volume: 34, Issue:1

    Topics: Adult; Antineoplastic Agents, Hormonal; Conservative Treatment; Cryopreservation; Embryo Transfer; Endometrial Neoplasms; Female; Fertility Preservation; Fertilization in Vitro; Humans; Letrozole; Levonorgestrel; Live Birth; Megestrol Acetate; Neoplasm Recurrence, Local; Nitriles; Pregnancy; Pregnancy Outcome; Triazoles

2018
Fertility Preserved Hysteroscopic Approach for the Treatment of Stage Ia Endometrioid Carcinoma.
    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2017, Volume: 27, Issue:9

    Topics: Adult; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Hysteroscopy; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Staging; Pregnancy; Retrospective Studies

2017
Pterostilbene, a natural phenolic compound, synergizes the antineoplastic effects of megestrol acetate in endometrial cancer.
    Scientific reports, 2017, 10-06, Volume: 7, Issue:1

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; Endometrial Neoplasms; Female; Humans; MAP Kinase Signaling System; Megestrol Acetate; Mice, Nude; Phenols; Signal Transduction; STAT3 Transcription Factor; Stilbenes; Xenograft Model Antitumor Assays

2017
Treatment efficiency of comprehensive hysteroscopic evaluation and lesion resection combined with progestin therapy in young women with endometrial atypical hyperplasia and endometrial cancer.
    Gynecologic oncology, 2019, Volume: 153, Issue:1

    Topics: Administration, Oral; Adult; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Hysteroscopy; Megestrol Acetate; Metformin; Middle Aged; Progestins; Retrospective Studies; Treatment Outcome; Young Adult

2019
Impact of treatment duration in fertility-preserving management of endometrial cancer or atypical endometrial hyperplasia.
    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2019, Volume: 29, Issue:4

    Topics: Adult; Antineoplastic Agents, Hormonal; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Gonadotropin-Releasing Hormone; Humans; Kaplan-Meier Estimate; Medroxyprogesterone; Megestrol Acetate; Pregnancy; Pregnancy Rate; Retrospective Studies; Treatment Outcome

2019
Hormone therapy following surgery in low-grade endometrial stromal sarcoma: Is it related to a decrease in recurrence rate?
    Journal of the Chinese Medical Association : JCMA, 2019, Volume: 82, Issue:5

    Topics: Adult; Combined Modality Therapy; Endometrial Neoplasms; Female; Humans; Hysterectomy; Lymph Node Excision; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Salpingo-oophorectomy; Sarcoma, Endometrial Stromal

2019
A prospective study of fertility-sparing treatment with megestrol acetate following hysteroscopic curettage for well-differentiated endometrioid carcinoma and atypical hyperplasia in young women.
    Archives of gynecology and obstetrics, 2013, Volume: 288, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Combined Modality Therapy; Curettage; Endometrial Neoplasms; Endometrium; Feasibility Studies; Female; Fertility Preservation; Humans; Hyperplasia; Hysteroscopy; Megestrol Acetate; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Rate; Prospective Studies; Young Adult

2013
Hormonal therapy for women with stage IA endometrial cancer of all grades.
    Obstetrics and gynecology, 2013, Volume: 122, Issue:1

    Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Cohort Studies; Endometrial Neoplasms; Female; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; Neoplasm Staging; Pregnancy; Pregnancy Outcome; Progestins; Retrospective Studies; Survival Rate; Treatment Outcome; Young Adult

2013
Sterol regulatory element-binding protein-1/fatty acid synthase involvement in proliferation inhibition and apoptosis promotion induced by progesterone in endometrial cancer.
    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2013, Volume: 23, Issue:9

    Topics: Antineoplastic Agents, Hormonal; Apoptosis; Cell Line, Tumor; Cell Proliferation; Endometrial Neoplasms; Fatty Acid Synthase, Type I; Female; Gene Expression Regulation, Neoplastic; Humans; Megestrol Acetate; Progesterone; Sterol Regulatory Element Binding Protein 1

2013
[Pregnant rate and pregnancy-relating factors of patients with early endometrial carcinoma and severe atypical hyperplasia of endometrium after fertility-preserving treatment by progestin].
    Zhonghua fu chan ke za zhi, 2013, Volume: 48, Issue:7

    Topics: Adult; Antineoplastic Agents, Hormonal; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Fertility Preservation; Humans; Infertility, Female; Medroxyprogesterone; Megestrol Acetate; Pregnancy; Pregnancy Outcome; Pregnancy Rate; Progestins; Reproductive Techniques, Assisted; Retrospective Studies; Treatment Outcome; Young Adult

2013
Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin.
    Gynecologic oncology, 2014, Volume: 133, Issue:2

    Topics: Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Hysterectomy; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Grading; Organ Sparing Treatments; Pregnancy; Pregnancy Outcome; Pregnancy Rate; Reproductive Techniques, Assisted; Retrospective Studies; Treatment Outcome

2014
Efficacy of IVF following conservative management of endometrial cancer.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2014, Volume: 30, Issue:4

    Topics: Adult; Endometrial Neoplasms; Female; Fertilization in Vitro; Humans; Megestrol Acetate; Ovulation Induction; Pregnancy

2014
Fenretinide: a novel treatment for endometrial cancer.
    PloS one, 2014, Volume: 9, Issue:10

    Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Progression; Endometrial Neoplasms; Female; Fenretinide; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Megestrol Acetate; Membrane Proteins; Mice, Nude; Vitamin A; Xenograft Model Antitumor Assays

2014
Oncologic and reproductive outcomes after fertility-sparing management with oral progestin for women with complex endometrial hyperplasia and endometrial cancer.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2016, Volume: 132, Issue:1

    Topics: Adult; Antineoplastic Agents, Hormonal; China; Disease-Free Survival; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility; Fertility Preservation; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; Obesity; Pregnancy; Progestins; Recurrence; Retrospective Studies; Treatment Outcome; Young Adult

2016
Clinicopathologic characteristics and treatment features of women with the incidental diagnosis of endometrial adenocarcinoma during infertility follow-up in Ankara, Turkey.
    Taiwanese journal of obstetrics & gynecology, 2016, Volume: 55, Issue:3

    Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Incidental Findings; Infertility, Female; Intrauterine Devices, Medicated; Levonorgestrel; Megestrol Acetate; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Pregnancy; Pregnancy Rate; Retrospective Studies; Turkey

2016
Fertility preserving treatment with hysteroscopic resection followed by progestin therapy in young women with early endometrial cancer.
    Journal of gynecologic oncology, 2017, Volume: 28, Issue:1

    Topics: Adult; Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Combined Modality Therapy; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Hysteroscopy; Intrauterine Devices; Levonorgestrel; Megestrol Acetate; Pregnancy; Progestins; Prospective Studies; Young Adult

2017
Does hormonal therapy for fertility preservation affect the survival of young women with early-stage endometrial cancer?
    Cancer, 2017, 05-01, Volume: 123, Issue:9

    Topics: Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Cause of Death; Cohort Studies; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Hysterectomy; Kaplan-Meier Estimate; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Grading; Propensity Score; Proportional Hazards Models; SEER Program; Time Factors; United States

2017
Progression of conservatively treated endometrial complex atypical hyperplasia in a young woman: a case report.
    Fertility and sterility, 2008, Volume: 90, Issue:5

    Topics: Abortion, Spontaneous; Adult; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma, Endometrioid; Chemotherapy, Adjuvant; Disease Progression; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Hysterectomy; Hysteroscopy; Laparoscopy; Megestrol Acetate; Neoplasm Staging; Ovariectomy; Ovulation Induction; Precancerous Conditions; Pregnancy; Radiotherapy, Adjuvant; Treatment Failure

2008
Conservative management of a patient with endometrial carcinoma desiring fertility: how to inform?
    European journal of gynaecological oncology, 2008, Volume: 29, Issue:6

    Topics: Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fertility; Humans; Megestrol Acetate; Patient Participation; Pregnancy

2008
Pregnancy outcomes using assisted reproductive technology after fertility-preserving therapy in patients with endometrial adenocarcinoma or atypical complex hyperplasia.
    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2009, Volume: 19, Issue:1

    Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Dilatation and Curettage; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Infertility, Female; Medroxyprogesterone Acetate; Megestrol Acetate; Pregnancy; Pregnancy Outcome; Reproductive Techniques, Assisted; Retrospective Studies

2009
The efficacy of hormonal treatment for residual or recurrent low-grade endometrial stromal sarcoma. A retrospective study.
    European journal of obstetrics, gynecology, and reproductive biology, 2009, Volume: 144, Issue:1

    Topics: Adult; Aged, 80 and over; Aromatase Inhibitors; Combined Modality Therapy; Dose-Response Relationship, Drug; Endometrial Neoplasms; Female; Humans; Hysterectomy; Letrozole; Megestrol Acetate; Middle Aged; Nitriles; Progestins; Retrospective Studies; Sarcoma, Endometrial Stromal; Secondary Prevention; Treatment Outcome; Triazoles

2009
Efficacy of megestrol acetate (megace) in the treatment of patients with early endometrial adenocarcinoma: our experiences with 21 patients.
    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2009, Volume: 19, Issue:2

    Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Female; Fertility; Humans; Infertility, Female; Megestrol Acetate; Middle Aged; Prospective Studies; Young Adult

2009
Case report: Successful IVF programme after conservatively treated endometrial cancer.
    Reproductive biomedicine online, 2009, Volume: 18, Issue:4

    Topics: Adult; Antineoplastic Agents, Hormonal; Embryo Transfer; Endometrial Neoplasms; Female; Fertilization in Vitro; Humans; Megestrol Acetate; Pregnancy; Pregnancy Outcome; Treatment Outcome

2009
Fertility-preserving treatment in young women with well-differentiated endometrial carcinoma and severe atypical hyperplasia of endometrium.
    Fertility and sterility, 2009, Volume: 92, Issue:6

    Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Antineoplastic Agents, Hormonal; Cell Differentiation; Combined Modality Therapy; Endometrial Neoplasms; Endometrium; Female; Fertility; Follow-Up Studies; Humans; Hydroxyprogesterones; Hyperplasia; Infertility, Female; Medroxyprogesterone Acetate; Megestrol Acetate; Progestins; Remission Induction; Reproductive Techniques, Assisted; Retrospective Studies; Severity of Illness Index

2009
Conservative treatment with progestin and pregnancy outcomes in endometrial cancer.
    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2009, Volume: 19, Issue:6

    Topics: Adult; Algorithms; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fertility; Follow-Up Studies; Gynecologic Surgical Procedures; Humans; Infertility, Female; Medroxyprogesterone Acetate; Megestrol Acetate; Pregnancy; Pregnancy Outcome; Progestins; Remission Induction; Retrospective Studies; Treatment Outcome; Young Adult

2009
Outcomes of conservative therapy for young women with early endometrial adenocarcinoma.
    Fertility and sterility, 2010, Volume: 93, Issue:1

    Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Female; Fertility; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Staging; Pregnancy; Pregnancy Outcome; Reproductive Techniques, Assisted; Retrospective Studies; Treatment Outcome

2010
Megestrol acetate therapy for advanced low-grade endometrial stromal sarcoma.
    Onkologie, 2010, Volume: 33, Issue:5

    Topics: Adult; Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Drug Administration Schedule; Endometrial Neoplasms; Fallopian Tubes; Female; Humans; Lung Neoplasms; Megestrol Acetate; Neoplasm Staging; Omentum; Ovariectomy; Palliative Care; Sarcoma, Endometrial Stromal

2010
The effect of operative hysteroscopy conducted before progestin treatment in early stage endometrial cancer from the view of fertility.
    Gynecologic oncology, 2011, Volume: 123, Issue:2

    Topics: Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Female; Humans; Levonorgestrel; Megestrol Acetate

2011
Pregnancy outcome in patients with stage 1a endometrial adenocarcinoma, who conservatively treated with megestrol acetate.
    Archives of gynecology and obstetrics, 2012, Volume: 285, Issue:3

    Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Hysterectomy; Megestrol Acetate; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Receptors, Estrogen; Receptors, Progesterone; Treatment Outcome; Young Adult

2012
[Regulation of claudin-4 gene expression in endometrial adenocarcinoma Ishikawa cell line by progesterone].
    Zhonghua fu chan ke za zhi, 2012, Volume: 47, Issue:5

    Topics: Adenocarcinoma; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Claudin-4; Endometrial Neoplasms; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Megestrol Acetate; Progesterone; Real-Time Polymerase Chain Reaction; RNA, Messenger; Time Factors

2012
Assessing endometrial hyperplasia and carcinoma treated with progestin therapy.
    American journal of clinical pathology, 2012, Volume: 138, Issue:4

    Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Agents, Hormonal; Cohort Studies; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Humans; Levonorgestrel; Megestrol Acetate; Menopause; Middle Aged; Prognosis; Treatment Failure; Young Adult

2012
Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002).
    European journal of cancer (Oxford, England : 1990), 2013, Volume: 49, Issue:4

    Topics: Administration, Oral; Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Cohort Studies; Endometrial Neoplasms; Female; Fertility Preservation; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Pregnancy; Prognosis; Survival Rate; Young Adult

2013
Altered claudin-4 expression in progesterone-treated endometrial adenocarcinoma cell line Ishikawa.
    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2012, Volume: 22, Issue:9

    Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Shape; Claudin-4; Dose-Response Relationship, Drug; Down-Regulation; Drug Evaluation, Preclinical; Endometrial Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; Megestrol Acetate; Progesterone

2012
Pregnancy outcomes after fertility-sparing management in young women with early endometrial cancer.
    Obstetrics and gynecology, 2013, Volume: 121, Issue:1

    Topics: Abortion, Spontaneous; Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Disease-Free Survival; Endometrial Neoplasms; Female; Fertility Agents; Humans; Infant, Newborn; Infertility, Female; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Grading; Neoplasm Staging; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Pregnancy Rate; Pregnancy, Ectopic; Premature Birth; Retrospective Studies; Treatment Outcome; Young Adult

2013
Progestin re-treatment in patients with recurrent endometrial adenocarcinoma after successful fertility-sparing management using progestin.
    Gynecologic oncology, 2013, Volume: 129, Issue:1

    Topics: Adenocarcinoma; Adult; Endometrial Neoplasms; Female; Fertility Preservation; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; Progestins; Recurrence

2013
Calcifications in ovary and endometrium and their neoplasms.
    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2003, Volume: 16, Issue:3

    Topics: Animals; Calcinosis; Chorionic Gonadotropin; Clomiphene; Dihydrotestosterone; Endometrial Neoplasms; Endometrium; Estradiol; Estrone; Female; Growth Hormone; Guinea Pigs; Hormones; Megestrol Acetate; Ovarian Neoplasms; Ovary; Prolactin; Tamoxifen; Testosterone

2003
A successful pregnancy after intracytoplasmic sperm injection and embryo transfer in a patient with endometrial cancer who was treated conservatively.
    Fertility and sterility, 2004, Volume: 81, Issue:1

    Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Cesarean Section; Embryo Transfer; Endometrial Neoplasms; Female; Humans; Magnetic Resonance Imaging; Medroxyprogesterone Acetate; Megestrol Acetate; Pregnancy; Pregnancy Outcome; Progesterone; Sperm Injections, Intracytoplasmic; Ultrasonography

2004
What is the clinical value of adding tamoxifen to progestins in the treatment [correction for treament] of advanced or recurrent endometrial cancer?
    Gynecologic oncology, 2004, Volume: 92, Issue:1

    Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase II as Topic; Drug Synergism; Endometrial Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; Receptors, Progesterone; Tamoxifen

2004
Multiple meningiomas arising during long-term therapy with the progesterone agonist megestrol acetate. Case report.
    Journal of neurosurgery, 2004, Volume: 100, Issue:2

    Topics: Dementia; Embolization, Therapeutic; Endometrial Neoplasms; Female; Gynecologic Surgical Procedures; Humans; Magnetic Resonance Imaging; Megestrol Acetate; Meningeal Neoplasms; Meningioma; Middle Aged; Neurosurgical Procedures; Progesterone; Progestins; Radiosurgery; Sarcoma, Endometrial Stromal; Time Factors

2004
Recurrence of prolactin-producing endometrial stromal sarcoma with sex-cord stromal component treated with progestin and aromatase inhibitor.
    Gynecologic oncology, 2004, Volume: 94, Issue:2

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Endometrial Neoplasms; Enzyme Inhibitors; Female; Humans; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Progestins; Prolactin; Sarcoma, Endometrial Stromal; Triazoles

2004
Ovarian metastasis in a nulliparous woman with endometrial adenocarcinoma failing conservative hormonal treatment.
    Gynecologic oncology, 2005, Volume: 97, Issue:2

    Topics: Adenocarcinoma; Adult; Combined Modality Therapy; Endometrial Neoplasms; Female; Humans; Megestrol Acetate; Ovarian Neoplasms

2005
Megestrol acetate induced hypoadrenalism with cushingoid phenotype in endometrial cancer.
    Gynecologic oncology, 2006, Volume: 101, Issue:1

    Topics: Adrenal Insufficiency; Adrenocorticotropic Hormone; Endometrial Neoplasms; Female; Humans; Hydrocortisone; Megestrol Acetate; Middle Aged

2006
Endometrial adenocarcinoma presenting with an osseous metastasis.
    Gynecologic and obstetric investigation, 2006, Volume: 61, Issue:4

    Topics: Adenocarcinoma; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Combined Modality Therapy; Doxorubicin; Endometrial Neoplasms; Female; Humans; Hysterectomy; Megestrol Acetate; Middle Aged

2006
[Progesterone-modulated proteins in human endometrial cancer cell line Ishikawa].
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2006, Volume: 26, Issue:8

    Topics: Adenocarcinoma; Cell Line, Tumor; Down-Regulation; Electrophoresis, Gel, Two-Dimensional; Endometrial Neoplasms; Female; Humans; Mass Spectrometry; Megestrol Acetate; Progesterone; Proteins; Proteome; Up-Regulation

2006
Evaluation of prognostic factors and comparison of systemic treatment modalities in patients with recurrent or metastatic endometrial carcinoma.
    Medical oncology (Northwood, London, England), 2006, Volume: 23, Issue:4

    Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cyclophosphamide; Doxorubicin; Endometrial Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Paclitaxel; Prognosis; Retrospective Studies; Survival Analysis; Treatment Outcome

2006
Stage III endometrial cancer: preoperative predictability, prognostic factors, and treatment outcome.
    American journal of obstetrics and gynecology, 2007, Volume: 196, Issue:6

    Topics: Adnexa Uteri; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Canada; Carcinoma; Chemotherapy, Adjuvant; Cystadenoma, Serous; Endometrial Neoplasms; Fallopian Tubes; Female; Humans; Hysterectomy; Lymph Node Excision; Megestrol Acetate; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Ovariectomy; Prognosis; Radiotherapy, Adjuvant; Registries

2007
Occult myometrial recurrence after progesterone therapy to preserve fertility in a young patient with endometrial cancer.
    Fertility and sterility, 2008, Volume: 89, Issue:3

    Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Dilatation and Curettage; Endometrial Neoplasms; Female; Fertility; Humans; Hysterectomy, Vaginal; Hysteroscopy; Infertility, Female; Laparoscopy; Magnetic Resonance Imaging; Megestrol Acetate; Myometrium; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Ovariectomy; Pregnancy; Progestins; Quality of Life; Reproductive Techniques, Assisted; Surrogate Mothers; Treatment Outcome

2008
Successful pregnancy after tamoxifen and megestrol acetate therapy for endometrial carcinoma.
    British journal of obstetrics and gynaecology, 1994, Volume: 101, Issue:6

    Topics: Adenocarcinoma; Adult; Endometrial Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Pregnancy; Tamoxifen

1994
Uterine adenocarcinoma metastatic to the skin responsive to megestrol acetate.
    The Journal of dermatologic surgery and oncology, 1994, Volume: 20, Issue:8

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Drug Resistance; Endometrial Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Skin Neoplasms

1994
Hyperglycemia secondary to megestrol acetate for endometrial neoplasia.
    Gynecologic oncology, 1996, Volume: 61, Issue:1

    Topics: Adenocarcinoma; Adenoma; Antineoplastic Agents; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Hyperglycemia; Insulin; Megestrol; Megestrol Acetate; Middle Aged

1996
Progestin regulation of vascular endothelial growth factor in human breast cancer cells.
    Cancer research, 1998, Feb-01, Volume: 58, Issue:3

    Topics: Breast Neoplasms; Endometrial Neoplasms; Endothelial Growth Factors; Female; Gene Expression Regulation, Neoplastic; Humans; Lymphokines; Medroxyprogesterone Acetate; Megestrol Acetate; Mifepristone; Neoplasm Proteins; Neovascularization, Pathologic; Norethindrone; Norethynodrel; Norgestrel; Progesterone; Progestins; Receptors, Progesterone; Stimulation, Chemical; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

1998
Low-grade endometrial stromal sarcoma preoperative treatment with Depo-Lupron and Megace.
    Gynecologic oncology, 1998, Volume: 71, Issue:3

    Topics: Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Female; Humans; Leuprolide; Megestrol Acetate; Middle Aged; Sarcoma, Endometrial Stromal

1998
Well-differentiated endometrial adenocarcinoma in an infertility patient with later conception. A case report.
    The Journal of reproductive medicine, 1999, Volume: 44, Issue:1

    Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Diagnosis, Differential; Endometrial Neoplasms; Female; Fertilization; Humans; Infertility, Female; Megestrol Acetate; Pregnancy

1999
The combination paclitaxel, carboplatin and megestrol acetate is effective in women with recurrent uterine papillary serous adenocarcinoma.
    European journal of gynaecological oncology, 1999, Volume: 20, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cystadenocarcinoma, Papillary; Endometrial Neoplasms; Female; Humans; Megestrol Acetate; Paclitaxel; Prognosis; Treatment Outcome

1999
Hemostatic effects of high-dose megestrol acetate therapy in patients with advanced gynecological cancer.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2001, Volume: 15, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Blood Coagulation; Breast Neoplasms; Endometrial Neoplasms; Female; Fibrinolysis; Genital Neoplasms, Female; Humans; Megestrol Acetate; Middle Aged; Ovarian Neoplasms; Thrombosis

2001
Two successful pregnancies after conservative treatment of endometrial cancer and assisted reproduction.
    Fertility and sterility, 2002, Volume: 77, Issue:1

    Topics: Adenocarcinoma; Adult; Delivery, Obstetric; Endometrial Neoplasms; Endometrium; Female; Humans; Infant, Newborn; Megestrol Acetate; Pregnancy; Reproductive Techniques, Assisted

2002
Fertility-preserving treatment in young patients with endometrial adenocarcinoma.
    Cancer, 2002, Apr-15, Volume: 94, Issue:8

    Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Disease Progression; Endometrial Neoplasms; Female; Fertility; Gonadotropin-Releasing Hormone; Humans; Megestrol; Megestrol Acetate; Pelvis; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Treatment Outcome; Ultrasonography

2002